Atara Biotherap (ATRA)
6.93 +0.04 (+0.58%) 01/23/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 7.23 +0.30 (+4.27%) 16:00 ET
for Thu, Jan 23rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 40,190 | 28,640 | 27,357 | 4,252 | 2,138 |
Cost of Goods | 7,602 | 4,627 | 1,985 | 3,160 | 2,615 |
Gross Profit | 32,588 | 24,013 | 25,372 | 1,092 | -477 |
Operating Expenses | 54,947 | 42,871 | 57,604 | 61,214 | 69,750 |
Operating Income | -21,757 | -18,231 | -31,247 | -59,962 | -69,612 |
Interest Expense | 1,183 | 1,262 | 1,153 | 1,176 | 1,395 |
Other Income | 1,014 | 444 | 672 | 699 | 1,191 |
Pre-tax Income | -21,926 | -19,049 | -31,728 | -60,439 | -69,816 |
Income Tax | -17 | N/A | 24 | 11 | -19 |
Net Income Continuous | -21,909 | -19,049 | -31,752 | -60,450 | -69,797 |
Net Income | $-21,909 | $-19,049 | $-31,752 | $-60,450 | $-69,797 |
EPS Basic Total Ops | -2.93 | -3.10 | -5.75 | -13.94 | -16.40 |
EPS Basic Continuous Ops | -2.93 | -3.10 | -5.65 | -13.89 | -16.40 |
EPS Diluted Total Ops | -2.93 | -3.10 | -5.75 | -13.94 | -16.40 |
EPS Diluted Continuous Ops | -2.93 | -3.10 | -5.65 | -13.89 | -16.40 |
EPS Diluted Before Non-Recurring Items | N/A | -3.10 | -5.75 | -14.00 | -16.50 |
EBITDA(a) | $-20,584 | $-16,911 | $-29,819 | $-56,645 | $-68,617 |